Yatharth Hospital Surges on Favorable CGHS Rate Revision

Shares of Yatharth Hospital & Trauma Care Services Ltd. experienced a significant rally, surging over 10% to reach a new all-time high of ₹839. This strong upward momentum is directly attributable to a positive regulatory development from the Union Health Ministry. The ministry has announced a comprehensive revision of rates for approximately 2,000 medical procedures under the Central Government Health Services (CGHS) scheme, effective October 13. This is the first major rate overhaul since 2014 and is structured to directly benefit organized, high-quality healthcare providers. The new multi-tiered rate structure is particularly advantageous for accredited institutions. Notably, super-specialty hospitals with over 200 beds are positioned to receive a 15% premium over the standard base rate. Conversely, non-accredited facilities will face a 15% rate reduction. This policy is expected to significantly enhance revenue streams and profitability for well-positioned, compliant players like Yatharth Hospital, which caters to a large number of CGHS beneficiaries. This positive development is underpinned by the company's robust financial performance, highlighted by a recent 40% year-over-year increase in net profit and a 22% rise in revenue, all while maintaining healthy EBITDA margins of 25%. The stock's strong technical posture, trading well above all key short and long-term moving averages, further reinforces the bullish market sentiment. This regulatory tailwind strengthens the company's growth outlook within a supportive healthcare sector.